简体中文 | 繁體中文 | English

Press Releases

2013-06-24 10:54 International Congress on Traditional Asian Medicine to Be Held in Korea, September 2013
2013-06-24 10:02 The Coca-Cola Foundation Gives Back $36 Million to Raise Living Standards Worldwide
2013-06-21 17:45 Sino Legend Prevails in Landmark Legal Challenge; Court Rejects SI Group Trade Secret Arguments
2013-06-21 17:37 NIKE Announces Strategic Leadership Changes
2013-06-21 17:27 Toshiba Launches New MOSFET "SSM3K337R" for Relay Drivers
2013-06-21 16:18 GE Healthcare Agrees to Acquire Certain Assets of Rayence, a Subsidiary of Vatech, Acknowledging Korea’s Technology in Mammography
2013-06-21 14:24 Camstar Manufacturing Execution System in Production at Infineon
2013-06-21 14:15 KCI Initiates Negative Pressure Wound Therapy with Instillation Randomized, Controlled Prospective Study
2013-06-21 11:24 CLOTS 3 Study Delivers Lifesaving Results Using Covidien’s Blood Clot Prevention Technology
2013-06-20 18:03 Union Bancaire Privée : Rebuilding Europe
2013-06-20 17:54 Another Step towards Olympic and Paralympic Games in Oslo
2013-06-20 16:18 Aéroports de Paris Exhibits Jean Dubuffet - the Hourloupe Cycle; from Painting to Monumental Sculpture, in the Espace Musées (Museum Area) of Paris-Charles De Gaulle Airport
2013-06-20 16:09 Supernet Signs Multi-Year Contract with SES for GSM Backhaul
2013-06-20 15:56 Gemalto deploys first contactless cards in Latvia for SEB
2013-06-20 14:36 Nobel Prize Laureatte, Dr. Louis J. Ignarro Shares with Asian Physicians Key Information about His Breakthrough Research in Heart Disease Prevention
2013-06-20 14:23 JOHNNIE WALKER® BLUE LABEL™ and Alfred Dunhill Unveil Limited Edition Collection in the Face of Resilient Luxury Industry
2013-06-20 10:51 SES and IPMTV Broaden Partnership
2013-06-20 10:43 MediaScape / Cignal TV Extends Partnership with SES
2013-06-20 10:23 Wolters Kluwer Health Expands UpToDate Clinical Decision Support Search and Navigation to 9 Languages
2013-06-20 10:12 Takeda and Seattle Genetics Highlight Post-Hoc Analysis Examining Progression-free Survival with ADCETRIS® (brentuximab vedotin) Versus Prior Therapy at the International Conference on Malignant Lymphoma